Michelle Quynhnhu Nguyen
Physician Assistant · Scottsdale, AZNPI 1467737338
Payments from drug & device makers
Across 137 payments — averaging $23.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$653
- Lilly USA, LLC$597
- Dexcom, Inc.$397
- Amgen$221
- AbbVie$148
- Rhythm Pharmaceuticals, Inc.$144
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,267100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 11 | $653 |
| Lilly USA, LLC | 34 | $597 |
| Dexcom, Inc. | 21 | $397 |
| Amgen | 15 | $221 |
| AbbVie | 8 | $148 |
| Rhythm Pharmaceuticals, Inc. | 2 | $144 |
| BETA Bionics, Inc. | 1 | $129 |
| Intuity Medical Inc | 1 | $120 |
| Xeris Pharmaceuticals, Inc. | 5 | $85 |
| Boehringer Ingelheim | 4 | $81 |
| Cequr Corporation | 3 | $81 |
| Radius Health, Inc. | 3 | $71 |
| Abbott | 3 | $64 |
| Merck | 1 | $62 |
| Novo Nordisk | 3 | $57 |
| Mannkind Corporation | 3 | $54 |
| Bayer | 3 | $51 |
| Insulet Corporation | 3 | $44 |
| Sanofi-aventis U.S. LLC | 3 | $42 |
| Recordati_rare_diseases_inc. | 2 | $42 |
| Verity Pharmaceuticals Inc. | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Ascendis Pharma Endocrinology Inc | 1 | $27 |
| Amphastar Pharmaceuticals, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,279 in reported general payments places this provider in the 85th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 178 | $293,506 |
| TrulicityDulaglutide | 75 | $133,884 |
| MounjaroTirzepatide | 55 | $85,011 |
| JardianceEmpagliflozin | 52 | $73,611 |
| FarxigaDapagliflozin Propanediol | 35 | $52,263 |
| Tresiba Flextouch U-100Insulin Degludec | 38 | $46,566 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $41,253 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 18 | $21,612 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $19,987 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $16,645 |
| SynthroidLevothyroxine Sodium | 150 | $16,511 |
| SynjardyEmpagliflozin/Metformin Hcl | 14 | $13,951 |
| Humalog Kwikpen U-100Insulin Lispro | 28 | $11,968 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 23 | $11,444 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 78 | $10,386 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $57 | $293,506178 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $597 | $227,555153 claims |
| Boehringer IngelheimJardiance, Synjardy | $81 | $87,56266 claims |
| AstraZenecaFarxiga | $14 | $52,26335 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $42 | $22,38528 claims |
| AbbVieSynthroid | $148 | $16,511150 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Scottsdale
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Christopher BeroScottsdale$81K
- Sophia Au StengerScottsdale$21K
- Daniel SilverScottsdale$17K
- Kevin MadayagScottsdale$13K
- Vivian PerlmanScottsdale$13K
- Karin BrimhallScottsdale$12K
- Jenna HiltonGilbert$637K
- Nicole MaderaGlendale$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.